Document is current
Any future updates will be listed below
-
Authors
Vieta, Eduard
-
Funding
Funding for this research was provided by:
Servier
AstraZeneca
Stanley Medical Research Institute
Centro de Investigación Biomédica en Red de Salud Mental
Angelini Pharma
Cátedra Telefónica, Universidad de Oviedo
Seventh Framework Programme
Shire
Allergan
H. Lundbeck A/S
Bristol-Myers Squibb
Gedeon Richter
Takeda Pharmaceutical Company
Roche
Otsuka Pharmaceutical
Sunovion
Pfizer
Ministerio de Ciencia, Innovación y Universidades
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Disruptive treatments in psychiatry
Journal Title: Revista de Psiquiatría y Salud Mental (English Edition)
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rpsmen.2019.10.003
CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rpsm.2019.10.001
Content Type: article
Copyright: © 2019 SEP y SEPB. Published by Elsevier España, S.L.U. All rights reserved.
